Abstract | BACKGROUND: METHODS: RESULTS: Administration of PPAR-gamma agonist significantly decreased the number of nasal rubs, nasal histamine responsiveness, serum IgE, IL-5 production from the spleen, and eosinophilic infiltration in the nasal mucosa. Furthermore, PPAR-gamma was expressed in eosinophils and epithelial cells in the nasal mucosa by immunohistochemistry. CONCLUSIONS:
|
Authors | Naoko Fukui, Kohei Honda, Eiko Ito, Kazuo Ishikawa |
Journal | Allergology international : official journal of the Japanese Society of Allergology
(Allergol Int)
Vol. 58
Issue 2
Pg. 247-53
(Jun 2009)
ISSN: 1440-1592 [Electronic] England |
PMID | 19307774
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Interleukin-13
- Interleukin-5
- PPAR gamma
- Thiazolidinediones
- Immunoglobulin E
- Histamine
- Interferon-gamma
- Ovalbumin
- ciglitazone
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, pharmacology, therapeutic use)
- Behavior, Animal
(drug effects)
- Eosinophils
(metabolism, pathology)
- Epithelial Cells
(metabolism)
- Female
- Histamine
(pharmacology)
- Immunoglobulin E
(blood, immunology)
- Interferon-gamma
(metabolism)
- Interleukin-13
(metabolism)
- Interleukin-5
(metabolism)
- Mice
- Mice, Inbred BALB C
- Nasal Mucosa
(drug effects, metabolism, pathology)
- Ovalbumin
(immunology, pharmacology)
- PPAR gamma
(agonists, metabolism)
- Rhinitis, Allergic, Perennial
(drug therapy, immunology, metabolism, pathology)
- Sneezing
(drug effects)
- Spleen
(drug effects, metabolism)
- Thiazolidinediones
(administration & dosage, pharmacology, therapeutic use)
|